A 
0.00
—
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
—
FY2014FY2023
Net income
−$4.4m
FY2014FY2023
Free cash flow
−$8,520
FY2014FY2023
Shareholders' equity
−$2.0m
FY2014FY2023
Income statement
Fiscal years
| FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | −$350 |
| Gross profit | — | — | −$314 | −$1,635 | −$3,471 | −$4,833 | −$3,462 | — | — | −$350 |
| Research and development | $92,247 | $83,842 | $55,204 | $60,627 | $14,373 | $324,608 | $1.6m | $1.6m | $1.6m | $1.1m |
| Operating income | −$4.2m | $141,088 | −$248,000 | −$5.4m | −$915,170 | −$4.1m | −$4.5m | −$62,227 | −$16,757 | −$40,035 |
| Net income | −$4.4m | −$687,000 | −$876,000 | −$5.3m | −$936,380 | −$4.1m | −$4.4m | −$62,227 | −$16,757 | −$40,035 |
| Diluted earnings per share | -0.01 | -0.00 | -0.01 | -0.08 | -0.01 | -0.06 | -0.06 | -0.00 | -0.00 | -0.00 |
Balance sheet
At each fiscal year end
| FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $95,657 | $85,276 | $44,577 | $32,944 | $4.9m | $5.2m | $9.1m | $259 | $385 | $6,685 |
| Cash and short-term investments | $74,986 | $39,363 | $10,848 | $14,241 | $50,068 | $42,693 | $4.0m | $134 | $35 | $6,335 |
| Total liabilities | $2.1m | $1.8m | $2.7m | $2.7m | $2.4m | $2.1m | $1.5m | $72,573 | $11,437 | $980 |
| Debt | $210,975 | $219,687 | $592,008 | $521,844 | $264,907 | $137,340 | — | $8,559 | $10,000 | — |
| Shareholders' equity | −$2.0m | −$1.7m | −$2.7m | −$2.7m | $2.5m | $3.1m | $7.6m | −$72,314 | −$11,052 | $5,705 |
| Shares outstanding | 772m | 180m | 69m | 69m | 69m | 69m | 69m | 65m | 11m | 11m |
Cash flow
Fiscal years
| FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −$8,516 | −$312,663 | −$293,393 | −$251,327 | −$92,625 | −$2.6m | −$3.0m | −$11,460 | −$12,931 | −$40,010 |
| Capital spending | −$4 | −$3 | −$3 | — | — | −$4,073 | −$10,493 | −$10,493 | −$10,493 | −$10,493 |
| Free cash flow | −$8,520 | −$312,666 | −$293,396 | −$251,327 | −$92,625 | −$2.6m | −$3.0m | −$21,953 | −$23,424 | −$50,503 |
Latest quarters
By quarter end
| Mar 2024 | Dec 2023 | Sept 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sept 2022 | Jun 2022 | |
|---|---|---|---|---|---|---|---|---|
| Operating income | −$71,387 | −$125,000 | −$48,827 | −$100,323 | −$4.0m | −$123,000 | −$30,996 | −$128,000 |
| Net income | −$95,518 | −$148,000 | −$58,328 | −$105,163 | −$4.1m | −$150,000 | −$59,524 | −$646,000 |
| Diluted earnings per share | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 |
| Total assets | $48,614 | $26,175 | $95,657 | $37,060 | $52,298 | $60,576 | $85,276 | $71,869 |
| Cash and short-term investments | $1,392 | $19,182 | — | $2,472 | $2,221 | $47,553 | — | $10,516 |
| Debt | $303,962 | $225,702 | — | $215,507 | $220,403 | $227,156 | $91,967 | $136,011 |
| Shareholders' equity | −$2.2m | −$2.1m | −$2.0m | −$2.0m | −$1.9m | −$1.8m | −$1.7m | −$1.8m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Operating income | -7.9% | 0.8% | 94.9% |
| Net income | -6.0% | 1.7% | 95.8% |
Valuation history
At each fiscal year end
| FY2023 | |
|---|---|
| Price to earnings | -0.1 |
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 0% | 579% | 4124% | 1404% | 6416% | 2172% | -48% | -67% | 183% | 301% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 3.25-for-1 split · 20 Sept 2016
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.